3. A 48-year-old Saudi female presented to ER complaining
about seizures she was lethargic and apathetic when she
admitted, after a year her clinical conditioned worsened by
time and she died due to infections and multiple organ
failure, she had a history of several further major epileptic
fits subsequent 8 months prior to her death.
Case study
4. UnremarkableSystemic review
Unremarkable
Past surgical history
she had a history of several epileptic fits 8
months prior to her death.
Past history
Non-smoker and denies any past or
present use of alcohol
No significant family history of
neurological disorders were reported or
any cancer
Social, family history
5. Gradual mental deterioration.
Loss of memory.
Altered speech.
Inaccurate writing.
She had bilateral papilloedema.
+ve brisk reflexes on the right side.
Clinical examination
11. Significant mass effect in left frontal lobe, an intra axial space occupying lesion in
white matter.
T2 iso intense thick enhancing wall, eccentric nodule with T2 hyper intense central
non enhancing necrosis, Perilesional vasogenic odema.
enhancing bubbly lesion involving corpus callosum extending in right lateral ventricle.
Left lateral ventricle compressed, significant mid line shift with mid brain compression
20. .
Double staining of GFAP (red) and IDH1
R132H (brown) of oligodendroglioma infiltration
zone showing specific labelling of tumor cells but
not of GFAP positive reactive astrocytes
GFAP: Marker of glial differentiation Ki-67/MIB1: Assessment of proliferation
images showing a high Ki-67 proliferation index
in approximately 25%-30% of the tumor cells
Immunohistochemical
24. There is a U-shaped portion of pale eosinophilic tissue related to
the top edge, this represents near normal grey matter with a
central sulcus containing small blood vessels. To the left of the
“U” is a zone of variegated tissue. irregular areas of brightly
eosinophilic tissue are interspersed with basophilic zones, this is
the tumour. The more homogenous tissue on the other side of the
“U” is near normal white matter.
Macroscopic examination
30. -High grade astrocytoma (anaplastic, nuclear atypia, cellular pleomorphism, mitotic
activity) with either coagulation necrosis or microvascular
proliferation(formerly"endothelial proliferation")-
Usually hypercellular with mitotic figures (some atypical), multinucleated tumor cells,
bizarre nuclei, karyorrhectic cells.
-pseudopalisading necrosis
-Other less common features: epithelial structures (glandular or ribbon-like),
epithelioid cells with well-delineated cytoplasmic membranes, granular cells,
lipidized cells, macrophages .
Micro description
31. Externally, there is gross swelling of the left
frontal lobe with marked subfalcine herniation
A large tumour is present in the left frontal lobe
which extends to involve the meninges.
This tumour measures 8 cm in diameter
numerous foci of haemorrhage and tumour
necrosis.
Macroscopically, the lesion appears fairly well
demarcated from the surrounding brain tissue.
Autopsy
34. Background
Glioblastoma Multiforme:
-It is the most common malignant primary tumor of the brain.
-It is very aggressive, involving glial cells.
-GBM is 20% of all intracranial tumors and 52% of all tissue brain
tumors.
-GBM incidence is only 2–3 cases per 100,000 people in Europe and
North America.
-GBM differ in location within the CNS, in age and sex distribution, in
growth, in invasiveness, in histological features, in progression, & in
response to therapy.
35. There are 2 variants of GBM:
-Gliosarcoma
-Giant Cell Glioblastoma.
36. Causes
The exact cause is unknown but changes or loss of chromosome
17 & inactivation of p53 has a role.
-Gender: Men are more affected than women.
-Viruses: like CMV or SV40 may be the cause.
(There is some association of GBM with polyvinyl chloride,
radiation, malaria and lead exposure)
-Age: above fifty years.
-Ethnicity: Asians, Caucasians
37. Pathogenesis
GBM have necrotizing tissues which are surrounded by anaplastic
cells. This along with hyperplastic vessels distinguishes GBM from
astrocytomas grade III.
38. Types of GBM:-
Classical GBM:
This type has extra copies of the EGFR gene in 97% of cases. They have higher expression of
EGFR gene.
Proneural GBM:
This type shows greater alterations in IDHI, TP53, & in PDGFRA.
Mesenchymal GBM:
Alterations & mutations in Neurofibromatosis type 1(NF1).
39. Other types of GBM:-
1-Primary GBM is sixty percent. These manifest de novo .
2-Secondary GBM is 40% develop in younger patients less than forty five years of age.
40. Common genetic abnormalities are:
-LOH: Loss of heterozygosity on arm 10q, mutation of MDM2 are specific for GBM
associated with poor survival.
-Epidermal growth factor receptor gene, PTEN primary GBM.
-PDGF overexpressed, p53 deletes or alteres secondary GBM
Rare mutations:
MAC1-E1 – A, MAGE-E1 – A and NRP/B – A
41.
42.
43. Clinical Features:
Headache Vomiting
Impaired memory
Intellectual disability
Convulsions
Paralysis on one side of body
Personality changes
Lack of emotion
Seizures
Poor coordination
Impaired speech
Reduced ability to interpret
language
Motor disturbance
Agraphia
Paresthesia
Loss of positional
awareness of body
Sensory changes
Spatial disorientation
Seizures
44. GBM usually reappears although disease free condition is
achievable. Mostly it occurs within 3 cm of the original
site but may occur in 10–20% cases at distant sites.
Recurrences
45. Prognosis without treatment is three months survival , with
treatment it is upto two years.
Older patients have worse prognosis.
Cerebral edema is the common cause of death.
Patients who receive surgery, radiotherapy, and
Temozolomide chemotherapy have long –term benefit.
Prognosis
Editor's Notes
ايش هنا؟؟
ترتيب
On clinical examination she began to show a
gradual mental deterioration
loss of memory
altered speech +inaccurate writing.
she had bilateral papilloedema
+ve brisk reflexes on the right side
:Definition
These are lesions which expand in volume to displace normal neural structures & may lead to increase in intra – cranial pressure
No hx of cancer
MR spectroscopy has been used to help distinguish between tumor and nontumor lesions in the brain. An elevated choline peak suggests neoplasm.
subacute cerebral infarction
should not have elevated choline
tumefactive demyelination
often has an open ring pattern of enhancement
usually younger patient
cerebral abscess
presence of dual rim sign
لابوراتوري المفروض اول وحده بعد الاقزامينيشن
GFAP: Marker of glial differentiation
GFAP (Glial Fibrillary Acidic Protein) has
proven to be the most specific marker for cells
of astrocytic origin that distinguishes differentiated
astrocytes from other glial cells during the
development of the central nervous system
_________________________________________
Ki-67/MIB1: Assessment of proliferation
Ki67/MIB1 has been established as the reference
marker for assessing cellular proliferation in tumour
cells. The antibody identifies actively dividing cells
at all stages of the cell cycle (late G1, S, M and G2
phases), but does not recognize cells in G0 phase
2-greatly increased cellularity :
compared to the surrounding brain tissue. Many of these tumours show striking cellular pleomorphism, tumour giant cells and bizarre mitoses – thesefeatures are not present in this case
in a primary glial tumour equates with a high grade lesions, 3-tumour necrosis
a) hematoxylin-eosin stain, showing highly cellular atypia with hyperchromatic pleomorphic nuclei and mitosis, surrounded by abundant microvascular hyperplasia
Glioblastoma = Grade IV tumour:similar to that of anaplastic astrocytoma, in addition to feature of necrosis, vascular proliferation, and pseudopalisading nuclei)
The mounted specimen shows the brain after horizontal slicing. Externally, there is gross swelling of the left frontal lobe with marked subfalcine herniation
A large tumour is present in the left frontal lobe which extends to involve the meninges.
This tumour measures 8 cm in diameter numerous foci of haemorrhage and tumour
necrosis.
Macroscopically, the lesion appears fairly well demarcated from the surrounding brain tissue.
ايش هنا؟؟
ريسك فاكتور مو كوزيس
Malignant transformation from a low to anaplastic astrocytoma requires one to ten years. There is genuine evidence which indicates that primary & secondary GBMs are distinct entities. Different genetic pathways involve in GBM.
Epidermal growth factor receptor gene, PTEN more common in primary GBM.
-Platelet-derived growth factor–alpha gene PDGF overexpressed, p53 deletes or alteres it is typically In secondary GBM
Chromosomal and genetic aberrations involved in the genesis of glioblastoma. Shown are the relationships between survival, pathobiology, and the molecular lesions that lead to the formation of primary (de novo) and secondary (progressive) glioblastomas
Clinical features largely depend on the location of the tumor than on its pathological characteristics